Trials / Completed
CompletedNCT03540355
Efficacy and Safety of Cipros 20 Association on Dyslipidemia Treatment
Phase III, National, Multicenter, Randomized, Double-blind Clinical Trial, to Evaluate the Efficacy and Safety of Cipros 20 Association on the Dyslipidemia Treatment
- Status
- Completed
- Phase
- Phase 3
- Study type
- Interventional
- Enrollment
- 406 (actual)
- Sponsor
- EMS · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this study is to evaluate the efficacy of Cipros 20 association in the treatment of dyslipidemia treatment.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Cipros 20 association | oral, once a day |
| DRUG | Crestor 20 mg | Oral, once a day |
Timeline
- Start date
- 2021-03-02
- Primary completion
- 2025-01-23
- Completion
- 2025-01-23
- First posted
- 2018-05-30
- Last updated
- 2026-01-09
Locations
1 site across 1 country: Brazil
Source: ClinicalTrials.gov record NCT03540355. Inclusion in this directory is not an endorsement.